In vivo challenges of anti-diabetic peptide therapeutics: Gastrointestinal stability, toxicity and allergenicity
Authors:
- Pei Gee YapPYPei Gee Yap
- Chee Yuen GanCGChee Yuen Gan
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Trends in Food Science & Technology
- Vol. 105, 161-175
Abstract
No abstract availableKeywords
Funding Information
- Universiti Sains Malaysia (1001/CABR/8011045)
- Universiti Sains Malaysia (1001/CABR/AUPS001)
This publication has 121 references indexed in Scilit:
- In Silico Approach for Predicting Toxicity of Peptides and ProteinsPLOS ONE, 2013
- Production and Characterization of a New α-Glucosidase Inhibitory Peptide fromAspergillus oryzaeN159-1Mycobiology, 2013
- A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active siteBiochemical and Biophysical Research Communications, 2013
- P-glycoprotein Inhibition for Optimal Drug DeliveryDrug Target Insights, 2013
- Screening of an α-Amylase Inhibitor Peptide by Photolinker–Peptide ArrayBioscience, Biotechnology, and Biochemistry, 2012
- Transdermal Delivery of ProteinsAAPS PharmSciTech, 2011
- Overview of the immune responseJournal of Allergy and Clinical Immunology, 2010
- Immunotherapy with Allergen PeptidesAllergy, Asthma & Clinical Immunology, 2007
- Bioinformatics Approaches to Classifying Allergens and Predicting Cross-ReactivityImmunology and Allergy Clinics of North America, 2007
- THE SYNTHESIS OF AN OCTAPEPTIDE AMIDE WITH THE HORMONAL ACTIVITY OF OXYTOCINJournal of the American Chemical Society, 1953